FDA Escalates Recall of Inspire Medical’s Nerve-Stimulating Implant for Sleep Apnea

The FDA has issued a Class I recall for Inspire Medical’s nerve-stimulating implant used in treating obstructive sleep apnea due to a manufacturing defect. Despite no reported injuries, up to 32 devices may be impacted. Inspire Medical continues to expand its therapy offerings amidst the recall, with a projected revenue growth of 26% for 2024.